206 related articles for article (PubMed ID: 25664061)
1. Serum IL-17 and IL-6 increased accompany with TGF-β and IL-13 respectively in ulcerative colitis patients.
Feng JS; Yang Z; Zhu YZ; Liu Z; Guo CC; Zheng XB
Int J Clin Exp Med; 2014; 7(12):5498-504. PubMed ID: 25664061
[TBL] [Abstract][Full Text] [Related]
2. [Shuxuening injection combined with routine therapy in treating patients with active ulcerative colitis: an analysis of efficacy ].
Xie ZH; Wang TJ; Zheng YX; Huang FF; Wang ZM
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1164-7. PubMed ID: 25509255
[TBL] [Abstract][Full Text] [Related]
3. Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment.
Lopetuso LR; Corbi M; Scaldaferri F; Petito V; Graziani C; Castri F; Neri M; Gasbarrini A; Sgambato A; Papa A
Eur J Gastroenterol Hepatol; 2020 Dec; 32(12):1527-1532. PubMed ID: 32976192
[TBL] [Abstract][Full Text] [Related]
4. Immune system alterations in patients with inflammatory bowel disease during remission.
Sventoraityte J; Zvirbliene A; Kiudelis G; Zalinkevicius R; Zvirbliene A; Praskevicius A; Kupcinskas L; Tamosiūnas V
Medicina (Kaunas); 2008; 44(1):27-33. PubMed ID: 18277086
[TBL] [Abstract][Full Text] [Related]
5. Systemic Molecular Mediators of Inflammation Differentiate Between Crohn's Disease and Ulcerative Colitis, Implicating Threshold Levels of IL-10 and Relative Ratios of Pro-inflammatory Cytokines in Therapy.
Kiernan MG; Coffey JC; Sahebally SM; Tibbitts P; Lyons EM; O'leary E; Owolabi F; Dunne CP
J Crohns Colitis; 2020 Jan; 14(1):118-129. PubMed ID: 31241755
[TBL] [Abstract][Full Text] [Related]
6. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
Reinecker HC; Steffen M; Witthoeft T; Pflueger I; Schreiber S; MacDermott RP; Raedler A
Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
[TBL] [Abstract][Full Text] [Related]
7. Higher serum vitamin D levels are associated with protective serum cytokine profiles in patients with ulcerative colitis.
Gubatan J; Mitsuhashi S; Longhi MS; Zenlea T; Rosenberg L; Robson S; Moss AC
Cytokine; 2018 Mar; 103():38-45. PubMed ID: 29324259
[TBL] [Abstract][Full Text] [Related]
8. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
Wang ZL; Wang YD; Wang K; Li JA; Li L
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
[TBL] [Abstract][Full Text] [Related]
9. Expression and release of leptin and proinflammatory cytokines in patients with ulcerative colitis and infectious diarrhea.
Biesiada G; Czepiel J; Ptak-Belowska A; Targosz A; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T; Mach T
J Physiol Pharmacol; 2012 Oct; 63(5):471-81. PubMed ID: 23211301
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis.
Wine E; Mack DR; Hyams J; Otley AR; Markowitz J; Crandall WV; Leleiko N; Muise AM; Griffiths AM; Turner D
J Crohns Colitis; 2013 Dec; 7(11):916-22. PubMed ID: 23339932
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.
Mohammed Vashist N; Samaan M; Mosli MH; Parker CE; MacDonald JK; Nelson SA; Zou GY; Feagan BG; Khanna R; Jairath V
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011450. PubMed ID: 29338066
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy.
Baird AC; Mallon D; Radford-Smith G; Boyer J; Piche T; Prescott SL; Lawrance IC; Tulic MK
World J Gastroenterol; 2016 Nov; 22(41):9104-9116. PubMed ID: 27895398
[TBL] [Abstract][Full Text] [Related]
13. Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis.
Iboshi Y; Nakamura K; Fukaura K; Iwasa T; Ogino H; Sumida Y; Ihara E; Akiho H; Harada N; Nakamuta M
J Gastroenterol; 2017 Mar; 52(3):315-326. PubMed ID: 27178567
[TBL] [Abstract][Full Text] [Related]
14. Cytokine profile in children with inflammatory bowel disease.
Toptygina AP; Semikina EL; Bobyleva GV; Miroshkina LV; Petrichuk SV
Biochemistry (Mosc); 2014 Dec; 79(12):1371-5. PubMed ID: 25716731
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease.
Mazlam MZ; Hodgson HJ
Gut; 1992 Jun; 33(6):773-8. PubMed ID: 1624158
[TBL] [Abstract][Full Text] [Related]
16. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis.
Murata Y; Ishiguro Y; Itoh J; Munakata A; Yoshida Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():56-60. PubMed ID: 8563892
[TBL] [Abstract][Full Text] [Related]
17. Relationship of cytokines, oxidative stress and GI motility with bacterial overgrowth in ulcerative colitis patients.
Rana SV; Sharma S; Kaur J; Prasad KK; Sinha SK; Kochhar R; Malik A; Morya RK
J Crohns Colitis; 2014 Aug; 8(8):859-65. PubMed ID: 24456736
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of selected laboratory markers in ulcerative colitis.
Mańkowska-Wierzbicka D; Swora-Cwynar E; Poniedziałek B; Adamski Z; Dobrowolska A; Karczewski J
Eur Cytokine Netw; 2015; 26(2):26-37. PubMed ID: 26463466
[TBL] [Abstract][Full Text] [Related]
19. Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies.
Papo M; Quer JC; Gutierrez C; Broch M; Casellas F; Pastor RM; Olona M; Richart C
Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):413-20. PubMed ID: 10321759
[TBL] [Abstract][Full Text] [Related]
20. Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome.
Kalantari H; Taheri A; Yaran M
Adv Biomed Res; 2015; 4():85. PubMed ID: 26015911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
